Is There Still a Place for Dopamine in the Modern Intensive Care Unit?

Anesthesia and Analgesia

Volumn 98, Issue 2, 2004, Pages 461-468

  Debaveye, Yves A ^a   Van Den Berghe, Greet H ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOHYPOPHYSIS HORMONE; DOPAMINE; GROWTH HORMONE; HYPERTENSIVE FACTOR; LIOTHYRONINE; PROLACTIN; THYROTROPIN; THYROXINE;

ACUTE KIDNEY FAILURE; ARTIFICIAL VENTILATION; BLOOD FLOW; BLOOD VOLUME; CARDIOVASCULAR EFFECT; DISEASE EXACERBATION; DOSE RESPONSE; DRUG EFFECT; DRUG RESPONSE; HORMONE ACTION; HUMAN; HYPOVOLEMIA; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY FAILURE; LOW DRUG DOSE; PRIORITY JOURNAL; PROTECTION; RESPIRATORY FAILURE; REVIEW; SIDE EFFECT; STOMACH MOTILITY;

EID: 1642460005     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000096188.35789.37     Document Type: Review

References (71)

1. Goldberg LI. Dopamine: clinical uses of an endogenous catecholamine. N Engl J Med 1974;291:707-10.
2. D'Orio V, el Allaf D, Juchmes J, Marcelle R. The use of low doses of dopamine in intensive care medicine. Arch Int Physiol Biochim 1984;92:S11-20.
3. Juste RN, Moran L, Hooper J, Soni N. Dopamine clearance in critically ill patients. Intensive Care Med 1998;24:1217-20.
4. McDonald RH, Goldberg LI, McNay JL, Tuttle EP. Effect of dopamine in man: augmentation of sodium excretion, glomerular filtration rate, and renal plasma flow. J Clin Invest 1964;43: 1116-24.
5. Richer M, Robert S, Lebel M. Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man. Crit Care Med 1996;24:1150-6.
6. Hoogenberg K, Smit AJ, Girbes AR. Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit Care Med 1998;26:260-5.
7. Lee MR. Dopamine and the kidney: ten years on. Clin Sci (Lond) 1993;84:357-75.
8. Seri I, Kone BC, Gullans SR, et al. Locally formed dopamine inhibits Na+-K+-ATPase activity in rat renal cortical tubule cells. Am J Physiol 1988;255:F666-73.
9. Hubbard PC, Henderson IW. Renal dopamine and the tubular handling of sodium. J Mol Endocrinol 1995;14:139-55.
10. Brezis M, Rosen S, Silva P, Epstein FH. Renal ischemia: a new perspective. Kidney Int 1984;26:375-83.
11. Power DA, Duggan J, Brady HR. Renal-dose (low-dose) dopamine for the treatment of sepsis-related and other forms of acute renal failure: ineffective and probably dangerous. Clin Exp Pharmacol Physiol Suppl 1999;26:S23-8.
12. Duke GJ, Briedis JH, Weaver RA. Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine? Crit Care Med 1994;22:1919-25.
13. Flancbaum L, Choban PS, Dasta JF. Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients. Crit Care Med 1994;22:61-8.
14. Girbes AR, Lieverse AG, Smit AJ, et al. Lack of specific renal haemodynamic effects of different doses of dopamine after infrarenal aortic surgery. Br J Anaesth 1996;77:753-7.
15. Juste RN, Panikkar K, Soni N. The effects of low-dose dopamine infusions on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline. Intensive Care Med 1998;24:564-8.
16. Lherm T, Troche G, Rossignol M, et al. Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines. Intensive Care Med 1996;22:213-9.
17. Olson D, Pohlman A, Hall JB. Administration of low-dose dopamine to nonoliguric patients with sepsis syndrome does not raise intramucosal gastric pH nor improve creatinine clearance. Am J Respir Crit Care Med 1996;154:1664-70.
18. Tang AT, El-Gamel A, Keevil B, et al. The effect of 'renal-dose' dopamine on renal tubular function following cardiac surgery: assessed by measuring retinol binding protein (RBP). Eur J Cardiothorac Surg 1999;15:717-21.
19. Myles PS, Buckland MR, Schenk NJ, et al. Effect of "renal-dose" dopamine on renal function following cardiac surgery. Anaesth Intensive Care 1993;21:56-61.
20. Baldwin L, Henderson A, Hickman P. Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 1994;120:744-7.
21. ter Wee PM, Smit AJ, Rosman JB, et al. Effect of intravenous infusion of low-dose dopamine on renal function in normal individuals and in patients with renal disease. Am J Nephrol 1986;6:42-6.
22. Girbes AR, Patten MT, McCloskey BV, et al. The renal and neurohumoral effects of the addition of low-dose dopamine in septic critically ill patients. Intensive Care Med 2000;26:1685-9.
23. Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial - Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000;356: 2139-43.
24. Marik PE, Iglesias J. Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria: NORASEPT II Study Investigators. Am J Med 1999;107:387-90.
25. Chertow GM, Sayegh MH, Allgren RL, Lazarus JM. Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group. Am J Med 1996;101:49-53.
26. Kellum JA, Decker JM. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 2001;29:1526-31.
27. Marik PE. Low-dose dopamine: a systematic review. Intensive Care Med 2002;28:877-83.
28. Schaer GL, Fink MP, Parrillo JE. Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy. Crit Care Med 1985;13: 492-6.
29. Strigle TR, Petrinec D. The effect of renal range dopamine and norepinephrine infusions on the renal vasculature. Am Surg 1990;56:494-6.
30. Doig CJ, Sutherland LR, Sandham JD, et al. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med 1998;158:444-51.
31. Johnson DJ, Johannigman JA, Branson RD, et al. The effect of low dose dopamine on gut hemodynamics during PEEP ventilation for acute lung injury. J Surg Res 1991;50:344-9.
32. Giraud GD, MacCannell KL. Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation. J Pharmacol Exp Ther 1984;230:214-20.
33. Meier-Hellmann A, Reinhart K. Effects of catecholamines on regional perfusion and oxygenation in critically ill patients. Acta Anaesthesiol Scand Suppl 1995;107:239-48.
34. Segal JM, Phang PT, Walley KR. Low-dose dopamine hastens onset of gut ischemia in a porcine model of hemorrhagic shock. J Appl Physiol 1992;73:1159-64.
35. Germann R, Haisjackl M, Hasibeder W, et al. Dopamine and mucosal oxygenation in the porcine jejunum. J Appl Physiol 1994;77:2845-52.
36. Hasibeder W, Germann R, Wolf HJ, et al. Effects of short-term endotoxemia and dopamine on mucosal oxygenation in porcine jejunum. Am J Physiol 1996;270:G667-75.
37. Jakob SM, Ruokonen E, Takala J. Effects of dopamine on systemic and regional blood flow and metabolism in septic and cardiac surgery patients. Shock 2002;18:8-13.
38. Meier-Hellmann A, Bredle DL, Specht M, et al. The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock. Intensive Care Med 1997;23: 31-7.
39. Ruokonen E, Takala J, Kari A, et al. Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993;21: 1296-303.
40. Maynard ND, Bihari DJ, Dalton RN, et al. Increasing splanchnic blood flow in the critically ill. Chest 1995;108:1648-54.
41. Neviere R, Mathieu D, Chagnon JL, et al. The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med 1996;154:1684-8.
42. Gardeback M, Settergren G. Dopexamine and dopamine in the prevention of low gastric mucosal pH following cardiopulmonary by-pass. Acta Anaesthesiol Scand 1995;39:1066-70.
43. Marik PE, Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994;272:1354-7.
44. Marzio L, Neri M, Pieramico O, et al. Dopamine interrupts gastrointestinal fed motility pattern in humans: effect on motilin and somatostatin blood levels. Dig Dis Sci 1990;35:327-32.
45. Tarling MM, Toner CC, Withington PS, et al. A model of gastric emptying using paracetamol absorption in intensive care patients. Intensive Care Med 1997;23:256-60.
46. Dive A, Foret F, Jamart J, et al. Effect of dopamine on gastrointestinal motility during critical illness. Intensive Care Med 2000;26:901-7.
47. van de Borne P, Oren R, Somers VK. Dopamine depresses minute ventilation in patients with heart failure. Circulation 1998;98:126-31.
48. Shoemaker WC, Appel PL, Kram HB, et al. Comparison of hemodynamic and oxygen transport effects of dopamine and dobutamine in critically ill surgical patients. Chest 1989;96:120-6.
49. Johnson RL. Low-dose dopamine and oxygen transport by the lung. Circulation 1998;98:97-9.
50. Van den Berghe G, de Zegher F, Bouillon R. Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998;83:1827-34.
51. Van den Berghe G, Wouters P, Weekers F, et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab 1999;84:1311-23.
52. Van den Berghe G, de Zegher F, Lauwers P, Veldhuis JD. Growth hormone secretion in critical illness: effect of dopamine. J Clin Endocrinol Metab 1994;79:1141-6.
53. Van den Berghe G, de Zegher F, Lauwers P. Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol (Oxf) 1994;41:731-7.
54. Van den Berghe G, de Zegher F, Lauwers P, Veldhuis JD. Luteinizing hormone secretion and hypoandrogenemia in critically ill men: effect of dopamine. Clin Endocrinol (Oxf) 1994;41:563-9.
55. Van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 1996;24:1580-90.
56. Bernton EW, Meltzer MS, Holaday JW. Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 1988;239:401-4.
57. Mikawa K, Kusunoki M, Obara H, Iwai S. Effect of dopamine on plasma growth hormone and prolactin concentrations under anaesthesia. J Int Med Res 1988;16:403-12.
58. Devins SS, Miller A, Herndon BL, et al. Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients. Crit Care Med 1992;20:1644-9.
59. Bailey AR, Burchett KR. Effect of low-dose dopamine on serum concentrations of prolactin in critically ill patients. Br J Anaesth 1997;78:97-9.
60. Van den Berghe G, de Zegher F, Lauwers P. Dopamine suppresses pituitary function in infants and children. Crit Care Med 1994;22:1747-53.
61. Rohr O, Sawaya BE, Lecestre D, et al. Dopamine stimulates expression of the human immunodeficiency virus type 1 via NF-kappaB in cells of the immune system. Nucleic Acids Res 1999;27:3291-9.
62. Van den Berghe G, de Zegher F, Wouters P, et al. Dehydroepiandrosterone sulphate in critical illness: effect of dopamine. Clin Endocrinol (Oxf) 1995;43:457-63.
63. Van den Berghe G, de Zegher F, Veldhuis JD, et al. Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues. Clin Endocrinol (Oxf) 1997;47:599-612.
64. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 1999;27:639-60.
65. Martin C, Papazian L, Perrin G, et al. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993;103:1826-31.
66. Bellomo R, Kellum JA, Wisniewski SR, Pinsky MR. Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Respir Crit Care Med 1999;159:1186-92.
67. Treggiari MM, Romand JA, Burgener D, et al. Effect of increasing norepinephrine dosage on regional blood flow in a porcine model of endotoxin shock. Crit Care Med 2002;30:1334-9.
68. LeDoux D, Astiz ME, Carpati CM, Rackow EC. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000;28:2729-32.
69. Goncalves JA, Hydo LJ, Barie PS. Factors influencing outcome of prolonged norepinephrine therapy for shock in critical surgical illness. Shock 1998;10:231-6.
70. Martin C, Viviand X, Leone M, Thirion X. Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000;28:2758-65.
71. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.